Angiogenesis in Atherogenesis

Atherogenesis is the pathobiological process, which underlies atherosclerotic cardiovascular disease and evolves in the 3 stages of initiation, progression, and complication to clinical significance. Of note, this process is associated with neovascularization, and it was not until recently that the implications of angiogenesis in atherogenesis were delineated. This article gives an updated overview on this topic and briefly reflects on the similarities with neovessel formation in carcinogenesis.

[1]  M. Moses,et al.  Making the cut: protease-mediated regulation of angiogenesis. , 2006, Experimental cell research.

[2]  Erik L Ritman,et al.  Correlation of Vasa Vasorum Neovascularization and Plaque Progression in Aortas of Apolipoprotein E−/−/Low-Density Lipoprotein−/− Double Knockout Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[3]  C. Napoli,et al.  Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Aloke V. Finn,et al.  Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[5]  Marilena Loizidou,et al.  Endothelin-1 and angiogenesis in cancer. , 2005, Current vascular pharmacology.

[6]  Michael Simons,et al.  Role of Angiogenesis in Cardiovascular Disease : a Critical Appraisal , 2022 .

[7]  D. Edwards,et al.  Metalloproteinases and their inhibitors in tumor angiogenesis , 2005, International journal of cancer.

[8]  C. Napoli,et al.  New trends in anti-atherosclerotic agents. , 2005, Current medicinal chemistry.

[9]  M. Sharma,et al.  Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis , 2005, Histopathology.

[10]  Philip J. Barter,et al.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.

[11]  M. Simons.  Angiogenesis: where do we stand now? , 2005, Circulation.

[12]  E. Pasquier,et al.  Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells. , 2005, Cancer research.

[13]  S. North,et al.  Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. , 2005, Cancer letters.

[14]  E. Geissler,et al.  Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[15]  O. Feron,et al.  Innate immunity and angiogenesis. , 2004, Circulation research.

[16]  R. Fritsche-Danielson,et al.  Role of ADAMTS-1 in atherosclerosis: remodeling of carotid artery, immunohistochemistry, and proteolysis of versican. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[17]  K. Sunagawa,et al.  Essential Role of Vascular Endothelial Growth Factor and Flt-1 Signals in Neointimal Formation After Periadventitial Injury , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Gieri Cathomas,et al.  Arterial Neovascularization and Inflammation in Vulnerable Patients: Early and Late Signs of Symptomatic Atherosclerosis , 2004, Circulation.

[19]  Henk-Jan Guchelaar,et al.  Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. , 2004, Cancer treatment reviews.

[20]  I. Shiojima,et al.  The role of vascular endothelial growth factor in restenosis: the controversy continues. , 2004, Circulation.

[21]  N. Ferrara,et al.  Angiogenesis-Dependent and Independent Phases of Intimal Hyperplasia , 2004, Circulation.

[22]  Juan J. Badimon,et al.  Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability , 2004, Circulation.

[23]  Amir Lerman,et al.  Adventitial vasa vasorum heterogeneity among different vascular beds. , 2004, Journal of vascular surgery.

[24]  S. Akira,et al.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Lee M Ellis,et al.  Neoplastic angiogenesis--not all blood vessels are created equal. , 2004, The New England journal of medicine.

[26]  J. Simons,et al.  HIF at the crossroads between ischemia and carcinogenesis , 2004, Journal of cellular physiology.

[27]  Robert S. Kerbel,et al.  The anti-angiogenic basis of metronomic chemotherapy , 2004, Nature Reviews Cancer.

[28]  W. Kamps,et al.  The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. , 2004, Critical reviews in oncology/hematology.

[29]  M. Frid,et al.  Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[30]  K. Moore,et al.  Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways , 2004, Nature Medicine.

[31]  Paul Schoenhagen,et al.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. , 2004, JAMA.

[32]  G. Lip,et al.  Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries , 2004, Journal of Clinical Pathology.

[33]  S. Tyagi,et al.  Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation , 2004, Cardiovascular Diabetology.

[34]  D. Harrison,et al.  Vascular Oxidant Stress Enhances Progression and Angiogenesis of Experimental Atheroma , 2004, Circulation.

[35]  B. Aggarwal,et al.  Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. , 2004, Cancer treatment and research.

[36]  K. Alitalo,et al.  Vascular endothelial growth factor-D expression in human atherosclerotic lesions. , 2003, Cardiovascular research.

[37]  P. Claudio,et al.  Molecular basis of angiogenesis and cancer , 2003, Oncogene.

[38]  A Vacca,et al.  New non-angiogenesis dependent pathways for tumour growth. , 2003, European journal of cancer.

[39]  B. Engelhardt,et al.  Multistep Nature of Microvascular Recruitment of Ex Vivo–expanded Embryonic Endothelial Progenitor Cells during Tumor Angiogenesis , 2003, The Journal of experimental medicine.

[40]  Mair Zamir,et al.  Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[41]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[42]  R. Giavazzi,et al.  Copyright © American Society for Investigative Pathology Distinct Role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on Tumor Growth and Angiogenesis , 2022 .

[43]  A. Newby,et al.  Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and Macrophages , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[44]  David Zurakowski,et al.  Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  F. Spinella,et al.  Emerging role of endothelin-1 in tumor angiogenesis , 2003, Trends in Endocrinology & Metabolism.

[46]  L. Lerman,et al.  Statin effects beyond lipid lowering--are they clinically relevant? , 2003, European heart journal.

[47]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[48]  A. Lametschwandtner,et al.  Vasa vasorum of the human great saphenous vein , 2002, Surgical and Radiologic Anatomy.

[49]  S. Kitano,et al.  Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor , 2002, Cancer Gene Therapy.

[50]  M. Dake,et al.  Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel. , 2002, Journal of vascular and interventional radiology : JVIR.

[51]  Masato Nakamura,et al.  Pathological significance of vascular endothelial growth factor A isoform expression in human cancer , 2002, Pathology international.

[52]  E. Ritman,et al.  Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 2002, Journal of the American College of Cardiology.

[53]  R. Macklis,et al.  Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix. , 2002, Vascular pharmacology.

[54]  C. Heeschen,et al.  Statins Have Biphasic Effects on Angiogenesis , 2002, Circulation.

[55]  E. Ritman,et al.  Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering , 2002, Circulation.

[56]  Keisuke Tokuda,et al.  Hypoxia-Inducible Factor-1&agr;/Vascular Endothelial Growth Factor Pathway for Adventitial Vasa Vasorum Formation in Hypertensive Rat Aorta , 2002, Hypertension.

[57]  A. Luttun,et al.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.

[58]  G. Ginsburg,et al.  Atherosclerosis: a cancer of the blood vessels? , 2001, American journal of clinical pathology.

[59]  D. Ribatti,et al.  Angiogenesis, angiogenic factor expression and hematological malignancies. , 2001, Anticancer research.

[60]  A. List.  Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. , 2001, The oncologist.

[61]  G. Koh,et al.  Angiopoietin-1 Reduces VEGF-Stimulated Leukocyte Adhesion to Endothelial Cells by Reducing ICAM-1, VCAM-1, and E-Selectin Expression , 2001, Circulation research.

[62]  R. Simari,et al.  The effect of endothelin-1 on nuclear factor kappa B in macrophages. , 2001, Biochemical and biophysical research communications.

[63]  E. Ritman,et al.  Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. , 2001, Cardiovascular research.

[64]  P. Libby,et al.  Drilling for oxygen: angiogenesis involves proteolysis of the extracellular matrix. , 2001, Circulation research.

[65]  M. Pepper.  Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[66]  R. Mofidi,et al.  Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease , 2001, The British journal of surgery.

[67]  P. Valent,et al.  Characterization of human prostate mast cells and their increase in periprostatic vein thrombosis. , 2001, American journal of clinical pathology.

[68]  M. Dake,et al.  Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.

[69]  P. Tsao,et al.  Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis , 2001, Nature Medicine.

[70]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[71]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[72]  P. Fasching,et al.  Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. , 2000, Diabetes.

[73]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[74]  M. Cybulsky,et al.  The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[75]  R. Fonseca,et al.  Prognostic value of bone marrow angiogenesis in multiple myeloma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[76]  P. Vallance,et al.  Endogenous factors involved in regulation of tone of arterial vasa vasorum: implications for conduit vessel physiology. , 2000, Cardiovascular research.

[77]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. , 2000, The American journal of pathology.

[78]  M. Mcmillen,et al.  Endothelins are angiogenic. , 2000, Journal of cardiovascular pharmacology.

[79]  J. Folkman,et al.  The generation of endostatin is mediated by elastase. , 1999, Cancer research.

[80]  M. Radomski,et al.  Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. , 1999, Circulation research.

[81]  J. Folkman,et al.  Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance* , 1999, The Journal of Biological Chemistry.

[82]  C. Weyand,et al.  Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. , 1999, The American journal of pathology.

[83]  M. Iruela-Arispe,et al.  METH-1, a Human Ortholog of ADAMTS-1, and METH-2 Are Members of a New Family of Proteins with Angio-inhibitory Activity* , 1999, The Journal of Biological Chemistry.

[84]  D. Woolley,et al.  Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries , 1999, The Journal of pathology.

[85]  L. Chandler,et al.  Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines , 1999, International journal of cancer.

[86]  P R Bell,et al.  Angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology , 1999, Journal of vascular surgery.

[87]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[88]  M A Konerding,et al.  Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.

[89]  J. Isner,et al.  Cancer and atherosclerosis: the broad mandate of angiogenesis. , 1999, Circulation.

[90]  O. Wiklund,et al.  Evidence of hypoxic areas within the arterial wall in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[91]  K. Nakagawa,et al.  Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[92]  E L Ritman,et al.  Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. , 1998, Journal of the American College of Cardiology.

[93]  R. Virmani,et al.  When neoangiogenesis ricochets. , 1998, American heart journal.

[94]  N. Tamura,et al.  Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. , 1998, Circulation.

[95]  S. Santilli,et al.  The Effect of Hypercholesterolemia on the Rabbit Transarterial Wall Oxygen Gradient , 1998, Annals of vascular surgery.

[96]  M. Kuzuya,et al.  Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[97]  H. Sugihara,et al.  Fibroblast growth factor-2 free from extracellular matrix is increased in papillary thyroid carcinomas and Graves' thyroids. , 1998, Thyroid : official journal of the American Thyroid Association.

[98]  E L Ritman,et al.  Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.

[99]  K. Peters,et al.  Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. , 1998, American heart journal.

[100]  J. Isner,et al.  Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. , 1997, The American journal of pathology.

[101]  C. Depré,et al.  Neovascularization in human coronary atherosclerotic lesions. , 1996, Catheterization and cardiovascular diagnosis.

[102]  S. Hughes.  Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries. , 1996, Cardiovascular research.

[103]  H. Hillen,et al.  Tumour angiogenesis: pathophysiology and clinical significance. , 1996, The Netherlands journal of medicine.

[104]  C. Alpers,et al.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.

[105]  J. Isner,et al.  Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. , 1995, Circulation.

[106]  K. Sueishi,et al.  Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. , 1995, Human pathology.

[107]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[108]  J. Park,et al.  The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. , 1993, Molecular biology of the cell.

[109]  P. Libby,et al.  Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. , 1993, The Journal of clinical investigation.

[110]  Yixia Zhang,et al.  Immunohistochemical study of intimal microvessels in coronary atherosclerosis. , 1993, The American journal of pathology.

[111]  D. Crossman,et al.  Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. , 1993, Cardiovascular Research.

[112]  E. Nabel,et al.  Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo , 1993, Nature.

[113]  J. Pisco,et al.  Vasa vasorum changes following stent placement in experimental arterial stenoses. , 1993, Journal of vascular and interventional radiology : JVIR.

[114]  J F Martin,et al.  Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[115]  E. Edelman,et al.  Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. , 1992, The Journal of clinical investigation.

[116]  R. Cardell,et al.  Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene. , 1991, The American journal of pathology.

[117]  A. Barger,et al.  Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. , 1990, The American journal of cardiology.

[118]  G. W. Boyd,et al.  HYPOTHESIS: ISCHAEMIC PLAQUE NECROSIS AS THE INITIATOR OF UNSTABLE ANGINA/ACUTE MYOCARDIAL INFARCTION? , 1990, Clinical and experimental pharmacology & physiology.

[119]  S. Brem,et al.  Angiogenic activity of the atherosclerotic carotid artery plaque. , 1989, Journal of neurosurgery.

[120]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[121]  A. Barger,et al.  Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysis. , 1987, Human pathology.

[122]  A. Penn,et al.  Transforming gene in human atherosclerotic plaque DNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[123]  A. Barger,et al.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.

[124]  M. Marcus,et al.  Hyperemia of the Aortic Wall in Atherosclerotic Monkeys , 1981, Circulation research.

[125]  S. Grundy,et al.  The possible role of the arterial microcirculation in the pathogenesis of atherosclerosis. , 1980, Journal of chronic diseases.

[126]  M. Marcus,et al.  Role of vasa vasorum in nourishment of the aorta. , 1979, Blood vessels.

[127]  W. Sterling Edwards,et al.  Blood Vessels , 1959 .